{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:41:35Z","timestamp":1791722495022,"version":"4.3.4"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"name":"IDEXX Laboratories, Inc."}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>This study demonstrates the utility of serum symmetric dimethylarginine (SDMA) as an excretory renal function biomarker in a rat model of gentamicin-induced proximal tubular injury.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Analytical and biologic validation of an SDMA immunoassay allows for future studies in rats using a high-throughput method.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Symmetric dimethylarginine (SDMA) is an excretory renal function biomarker shown to correlate well with glomerular filtration rate in dogs, cats, humans, and rats. The objectives of this study were to determine utility of serum SDMA as a renal biomarker in a rat model of gentamicin-induced renal injury and to provide validation of a commercially available SDMA immunoassay for rat serum. Rats were randomly assigned to one of three dose levels of gentamicin (20, 50, or 100 mg\/kg) or a vehicle control group and dosed once daily by subcutaneous injection for either four or ten days. Serum and urine renal biomarker evaluation, including serum SDMA, hematologic and serum biochemical analysis, urinalysis, and histologic examination of kidney, were performed. Before biologic validation, analytic validation of the SDMA immunoassay for rat serum was performed, including assessment of assay accuracy, precision, analytical sensitivity, linearity, analyte stability, and interference testing. Among markers of excretory renal function, SDMA and serum creatinine increased earliest and at the lowest gentamicin concentrations and were significantly increased in both the 50- and 100- mg\/kg dose levels in the four- and ten-dose treatment groups compared with controls. Time- and dose-dependent increases were noted for all urinary biomarkers investigated in this study, with microalbumin being most responsive and osteopontin least responsive for detection of gentamicin-induced injury across dose levels and schedules investigated. The SDMA immunoassay met all set quality requirements assessed in analytical validation. This study is the first to investigate performance of serum SDMA compared with other excretory renal function markers in a rat gentamicin acute toxicity model. In this study, serum SDMA was an earlier biomarker for detection of gentamicin-induced toxicity than serum cystatin C, BUN, and creatinine clearance. The SDMA immunoassay provides a reliable commercially available assay for future renal investigations in rat models.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0006542020","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T15:50:21Z","timestamp":1638892221000},"page":"341-356","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of Renal Biomarkers, Including Symmetric Dimethylarginine, following Gentamicin-Induced Proximal Tubular Injury in the Rat"],"prefix":"10.34067","volume":"3","author":[{"given":"Diane M.","family":"Hamlin","sequence":"first","affiliation":[{"name":"Pathology Department, Toxicology Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6731-7876","authenticated-orcid":false,"given":"A. Eric","family":"Schultze","sequence":"additional","affiliation":[{"name":"Pathology Department, Toxicology Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4107-2353","authenticated-orcid":false,"given":"Michael J.","family":"Coyne","sequence":"additional","affiliation":[{"name":"IDEXX Laboratories, Inc., Westbrook, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J.","family":"McCrann","sequence":"additional","affiliation":[{"name":"IDEXX Laboratories, Inc., Westbrook, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"Mack","sequence":"additional","affiliation":[{"name":"IDEXX Laboratories, Inc., Westbrook, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1517-7103","authenticated-orcid":false,"given":"Corie","family":"Drake","sequence":"additional","affiliation":[{"name":"IDEXX Laboratories, Inc., Westbrook, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2994-7794","authenticated-orcid":false,"given":"Rachel E.","family":"Murphy","sequence":"additional","affiliation":[{"name":"IDEXX Laboratories, Inc., Westbrook, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Cross","sequence":"additional","affiliation":[{"name":"IDEXX Laboratories, Inc., Westbrook, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Strong-Townsend","sequence":"additional","affiliation":[{"name":"IDEXX Laboratories, Inc., Westbrook, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Yerramilli","sequence":"additional","affiliation":[{"name":"IDEXX Laboratories, Inc., Westbrook, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4393-8616","authenticated-orcid":false,"given":"Mary K.","family":"Leissinger","sequence":"additional","affiliation":[{"name":"IDEXX Laboratories, Inc., Westbrook, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"B1-20250825","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/toxsci\/kfr339","article-title":"Evaluation of drugs with specific organ toxicities in organ-specific cell lines","volume":"126","author":"Lin","year":"2012","journal-title":"Toxicol Sci"},{"key":"B2-20250825","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0192623318789399","article-title":"Drug-induced glomerulonephritis: The spectre of biotherapeutic and antisense oligonucleotide immune activation in the kidney","volume":"46","author":"Frazier","year":"2018","journal-title":"Toxicol Pathol"},{"key":"B3-20250825","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0192623311432437","article-title":"Evaluation of novel urinary renal biomarkers with a cisplatin model of kidney injury: Effects of collection period","volume":"40","author":"Pinches","year":"2012","journal-title":"Toxicol Pathol"},{"key":"B4-20250825","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s13054-014-0601-2","article-title":"The clinical utility window for acute kidney injury biomarkers in the critically ill","volume":"18","author":"Ralib","year":"2014","journal-title":"Crit Care"},{"key":"B5-20250825","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/toxsci\/kfy159","article-title":"Nephrotoxicity and renal pathophysiology: A contemporary perspective","volume":"164","author":"Barnett","year":"2018","journal-title":"Toxicol Sci"},{"key":"B6-20250825","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/toxsci\/kfx239","article-title":"Multiscale mathematical model of drug-induced proximal tubule injury: Linking urinary biomarkers to epithelial cell injury and renal dysfunction","volume":"162","author":"Gebremichael","year":"2018","journal-title":"Toxicol Sci"},{"key":"B8-20250825","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.clinbiochem.2016.07.009","article-title":"Comparison of symmetric dimethylarginine with creatinine, cystatin C and their eGFR equations as markers of kidney function","volume":"49","author":"El-Khoury","year":"2016","journal-title":"Clin Biochem"},{"key":"B9-20250825","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00216-011-5462-9","article-title":"A simple and fast liquid chromatography-tandem mass spectrometry method for measurement of underivatized l-arginine, symmetric dimethylarginine, and asymmetric dimethylarginine and establishment of the reference ranges","volume":"402","author":"El-Khoury","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"B10-20250825","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrneph.2011.31","article-title":"The role of asymmetric and symmetric dimethylarginines in renal disease","volume":"7","author":"Schwedhelm","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"B11-20250825","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/jvim.13942","article-title":"Serum concentrations of symmetric dimethylarginine and creatinine in dogs with naturally occurring chronic kidney disease","volume":"30","author":"Hall","year":"2016","journal-title":"J Vet Intern Med"},{"key":"B12-20250825","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/jvim.12445","article-title":"Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease","volume":"28","author":"Hall","year":"2014","journal-title":"J Vet Intern Med"},{"key":"B13-20250825","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/jvim.12835","article-title":"Symmetric dimethylarginine assay validation, stability, and evaluation as a marker for the early detection of chronic kidney disease in dogs","volume":"29","author":"Nabity","year":"2015","journal-title":"J Vet Intern Med"},{"key":"B14-20250825","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/ndt\/gfg452","article-title":"Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia","volume":"18","author":"Nijveldt","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"B15-20250825","doi-asserted-by":"crossref","first-page":"H209","DOI":"10.1152\/ajpheart.00208.2005","article-title":"Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats","volume":"290","author":"Carello","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B16-20250825","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1093\/ndt\/gfl292","article-title":"Symmetric dimethylarginine (SDMA) as endogenous marker of renal function\u2014A meta-analysis","volume":"21","author":"Kielstein","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"B17-20250825","doi-asserted-by":"crossref","first-page":"F149","DOI":"10.1152\/ajprenal.00045.2012","article-title":"Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency","volume":"303","author":"Ronden","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"B18-20250825","first-page":"524","article-title":"NG, NG-dimethylarginine and NG, NG-dimethylarginine in renal insufficiency","volume":"439","author":"Al Banchaabouchi","year":"2000","journal-title":"Pflugers Arch"},{"key":"B19-20250825","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jchromb.2011.01.006","article-title":"Simultaneous bioanalysis of l-arginine, l-citrulline, and dimethylarginines by LC-MS\/MS","volume":"879","author":"Shin","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"B20-20250825","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/toxsci\/kfp070","article-title":"Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity","volume":"109","author":"Sieber","year":"2009","journal-title":"Toxicol Sci"},{"key":"B21-20250825","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/toxsci\/kfm260","article-title":"Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium","volume":"101","author":"Zhou","year":"2008","journal-title":"Toxicol Sci"},{"key":"B25-20250825","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1055\/s-0031-1296208","article-title":"Simultaneous determination of l-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in the plasma of rodents with LC-MS\/MS","volume":"61","author":"Chae","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"B27-20250825","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/clpt.2008.270","article-title":"Translational toxicology and the work of the predictive safety testing consortium","volume":"85","author":"Mattes","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"B28-20250825","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nbt.1634","article-title":"Towards consensus practices to qualify safety biomarkers for use in early drug development","volume":"28","author":"Sistare","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B29-20250825","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1373\/clinchem.2005.060152","article-title":"Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography-electrospray tandem mass spectrometry","volume":"52","author":"Martens-Lobenhoffer","year":"2006","journal-title":"Clin Chem"},{"key":"B30-20250825","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1373\/clinchem.2010.155895","article-title":"Simultaneous determination of 6 l-arginine metabolites in human and mouse plasma by using hydrophilic-interaction chromatography and electrospray tandem mass spectrometry","volume":"57","author":"Brown","year":"2011","journal-title":"Clin Chem"},{"key":"B31-20250825","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kft330","article-title":"Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies","volume":"138","author":"Vlasakova","year":"2014","journal-title":"Toxicol Sci"},{"key":"B32-20250825","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2460\/javma.1976.168.07.593","article-title":"Evaluation of blood urea nitrogen and serum creatinine concentrations as indicators of renal dysfunction: A study of 111 cases and a review of related literature","volume":"168","author":"Finco","year":"1976","journal-title":"J Am Vet Med Assoc"},{"key":"B33-20250825","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/0192623320985045","article-title":"A review of specific biomarkers of chronic renal injury and their potential application in nonclinical safety assessment studies","volume":"49","author":"Obert","year":"2021","journal-title":"Toxicol Pathol"},{"key":"B34-20250825","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1623","article-title":"Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies","volume":"28","author":"Vaidya","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B35-20250825","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tox.2010.08.013","article-title":"Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity","volume":"277","author":"Hoffmann","year":"2010","journal-title":"Toxicology"},{"key":"B36-20250825","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1535370217743949","article-title":"Preclinical biomarker qualification","volume":"243","author":"Sauer","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"key":"B37-20250825","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/0192623313520352","article-title":"Normal ranges and variability of novel urinary renal biomarkers in Sprague-Dawley rats: Comparison of constitutive values between males and females and across assay platforms","volume":"42","author":"Gautier","year":"2014","journal-title":"Toxicol Pathol"},{"key":"B38-20250825","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.toxrep.2018.11.015","article-title":"Gentamicin induced acute renal damage and its evaluation using urinary biomarkers in rats","volume":"6","author":"Udupa","year":"2019","journal-title":"Toxicol Rep"},{"key":"B39-20250825","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/ki.2009.501","article-title":"Major contribution of tubular secretion to creatinine clearance in mice","volume":"77","author":"Eisner","year":"2010","journal-title":"Kidney Int"},{"key":"B40-20250825","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/HYPERTENSIONAHA.113.01194","article-title":"Progression of glomerular filtration rate reduction determined in conscious Dahl salt-sensitive hypertensive rats [published correction appears in Hypertension 62: e12, 2013 10.1161\/HYP.0b013e3182a1ac71]","volume":"62","author":"Cowley","year":"2013","journal-title":"Hypertension"},{"key":"B41-20250825","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","article-title":"Aminoglycosides: nephrotoxicity","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0006542020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:02:39Z","timestamp":1786478559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0006542020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0006542020","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"2020-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}